| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | 0.565 | 0.692 | 2.4E-13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DnaJ heat shock protein family (Hsp40) member C21 | 0.606 | 0.731 | 2.1E-07 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
G protein-coupled receptor 183 | 0.700 | 0.462 | 1.7E-02 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Cbl proto-oncogene C | 0.821 | 0.192 | 4.2E-11 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
GRINL1B complex locus 2 (pseudogene) | 1.000 | 0.038 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
signal recognition particle 54 | 0.612 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
elongation factor like GTPase 1 | 0.638 | 0.577 | 5.1E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
caudal type homeobox 1 | 0.644 | 0.346 | 0.14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
antizyme inhibitor 2 | 0.499 | 0.808 | 8.9E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
SPO11 initiator of meiotic double stranded breaks | 0.821 | 0.192 | 1.4E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
LETM1 domain containing 1 | 0.682 | 0.308 | 4.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
glucose-6-phosphate isomerase | 0.491 | 0.769 | 2.8E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1995 | 1995 | ||||||||
|
C-X-C motif chemokine ligand 17 | 0.647 | 0.615 | 4.8E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1989 | 1989 | ||||||||
|
serrate, RNA effector molecule | 0.736 | 0.231 | 0.59 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
dymeclin | 0.563 | 0.769 | 3.6E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
SWT1 RNA endoribonuclease homolog | 0.839 | 0.115 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
isoleucyl-tRNA synthetase 2, mitochondrial | 0.590 | 0.654 | 8.1E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
tribbles pseudokinase 3 | 0.573 | 0.692 | 1.2E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 |